7-Oct-2026 - Fintel Barclays initiates coverage of Insulet at equal-weight Fintel reports that on 7 October 2026, Barclays initiated coverage of Insulet (XTRA:GOV) with a Equal-Weight recommendation. This initiation follows a prior action on 8 May 2026, when Barclays ...
11-Aug-2026 - MSN 5 must-read analyst questions from Insulet’s Q2 earnings call Insulet’s second quarter was marked by strong revenue expansion but a sharp negative market reaction, as investors focused on emerging challenges in the company’s type 2 diabetes segment. While ...
7-Oct-2026 - Fintel Barclays initiates coverage of Insulet at equal-weight Fintel reports that on 7 October 2026, Barclays initiated coverage of Insulet (XTRA:GOV) with a Equal-Weight recommendation. This initiation follows a prior action on 8 May 2026, when Barclays ...
11-Aug-2026 - MSN 5 must-read analyst questions from Insulet’s Q2 earnings call Insulet’s second quarter was marked by strong revenue expansion but a sharp negative market reaction, as investors focused on emerging challenges in the company’s type 2 diabetes segment. While ...
